AdaptHealth Future Growth
Future criteria checks 3/6
AdaptHealth is forecast to grow earnings and revenue by 89.2% and 3.4% per annum respectively. EPS is expected to grow by 90.4% per annum. Return on equity is forecast to be 10.8% in 3 years.
Key information
89.2%
Earnings growth rate
90.4%
EPS growth rate
Healthcare earnings growth | 18.7% |
Revenue growth rate | 3.4% |
Future return on equity | 10.8% |
Analyst coverage | Good |
Last updated | 06 Jan 2025 |
Recent future growth updates
Recent updates
AdaptHealth Corp.'s (NASDAQ:AHCO) Revenues Are Not Doing Enough For Some Investors
Dec 10We Think AdaptHealth (NASDAQ:AHCO) Is Taking Some Risk With Its Debt
Nov 13Returns On Capital Signal Tricky Times Ahead For AdaptHealth (NASDAQ:AHCO)
Oct 22AdaptHealth Corp.'s (NASDAQ:AHCO) Share Price Boosted 26% But Its Business Prospects Need A Lift Too
Sep 06Is There An Opportunity With AdaptHealth Corp.'s (NASDAQ:AHCO) 37% Undervaluation?
Jul 14AdaptHealth Corp.'s (NASDAQ:AHCO) Low P/S No Reason For Excitement
Jun 25AdaptHealth (NASDAQ:AHCO) Is Reinvesting At Lower Rates Of Return
Jun 04Here's Why AdaptHealth (NASDAQ:AHCO) Has A Meaningful Debt Burden
Apr 03Market Might Still Lack Some Conviction On AdaptHealth Corp. (NASDAQ:AHCO) Even After 50% Share Price Boost
Mar 07AdaptHealth's (NASDAQ:AHCO) Returns On Capital Not Reflecting Well On The Business
Feb 16Many Still Looking Away From AdaptHealth Corp. (NASDAQ:AHCO)
Jan 18AdaptHealth (NASDAQ:AHCO) Use Of Debt Could Be Considered Risky
Nov 15Returns On Capital At AdaptHealth (NASDAQ:AHCO) Paint A Concerning Picture
Oct 18Is It Too Late To Consider Buying AdaptHealth Corp. (NASDAQ:AHCO)?
Sep 27Here's What's Concerning About AdaptHealth's (NASDAQ:AHCO) Returns On Capital
Jul 19Here's Why AdaptHealth (NASDAQ:AHCO) Is Weighed Down By Its Debt Load
Jul 04Is Now The Time To Look At Buying AdaptHealth Corp. (NASDAQ:AHCO)?
Jun 16AdaptHealth's (NASDAQ:AHCO) Returns On Capital Not Reflecting Well On The Business
Apr 10Here's Why AdaptHealth (NASDAQ:AHCO) Is Weighed Down By Its Debt Load
Mar 22Why AdaptHealth Corp. (NASDAQ:AHCO) Could Be Worth Watching
Feb 23Investors Interested In AdaptHealth Corp.'s (NASDAQ:AHCO) Earnings
Jan 24AdaptHealth (NASDAQ:AHCO) Has A Somewhat Strained Balance Sheet
Dec 16We Ran A Stock Scan For Earnings Growth And AdaptHealth (NASDAQ:AHCO) Passed With Ease
Nov 28AdaptHealth named a Fresh Pick at Baird after investor day
Sep 19AdaptHealth: Operating Performance Stretching Up, Valuation Less So
Aug 30Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 3,513 | 145 | N/A | N/A | 7 |
12/31/2025 | 3,327 | 119 | 232 | 530 | 9 |
12/31/2024 | 3,234 | 75 | 176 | 476 | 9 |
9/30/2024 | 3,263 | -218 | 229 | 547 | N/A |
6/30/2024 | 3,261 | -690 | 166 | 501 | N/A |
3/31/2024 | 3,248 | -695 | 53 | 389 | N/A |
12/31/2023 | 3,200 | -679 | 143 | 481 | N/A |
9/30/2023 | 3,122 | -427 | 31 | 422 | N/A |
6/30/2023 | 3,075 | 42 | 22 | 431 | N/A |
3/31/2023 | 3,009 | 40 | 44 | 448 | N/A |
12/31/2022 | 2,971 | 63 | -18 | 374 | N/A |
9/30/2022 | 2,903 | 87 | 66 | 378 | N/A |
6/30/2022 | 2,800 | 125 | 20 | 298 | N/A |
3/31/2022 | 2,689 | 184 | 79 | 324 | N/A |
12/31/2021 | 2,465 | 142 | 72 | 276 | N/A |
9/30/2021 | 2,115 | 40 | 68 | 225 | N/A |
6/30/2021 | 1,746 | -64 | 124 | 232 | N/A |
3/31/2021 | 1,361 | -131 | 122 | 190 | N/A |
12/31/2020 | 1,071 | -162 | 156 | 196 | N/A |
9/30/2020 | 858 | -91 | 133 | 163 | N/A |
6/30/2020 | 710 | -44 | 124 | 145 | N/A |
3/31/2020 | 602 | -50 | 45 | 69 | N/A |
12/31/2019 | 530 | -21 | 39 | 60 | N/A |
9/30/2019 | 489 | -8 | 52 | 68 | N/A |
6/30/2019 | 454 | 8 | 57 | 72 | N/A |
3/31/2019 | 398 | 14 | 61 | 73 | N/A |
12/31/2018 | 345 | 23 | 58 | 68 | N/A |
12/31/2017 | 193 | 10 | N/A | 46 | N/A |
12/31/2016 | 174 | -4 | N/A | 30 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: AHCO is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.6%).
Earnings vs Market: AHCO is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: AHCO is expected to become profitable in the next 3 years.
Revenue vs Market: AHCO's revenue (3.4% per year) is forecast to grow slower than the US market (9% per year).
High Growth Revenue: AHCO's revenue (3.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: AHCO's Return on Equity is forecast to be low in 3 years time (10.8%).
Discover growth companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/01/15 01:53 |
End of Day Share Price | 2025/01/14 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
AdaptHealth Corp. is covered by 12 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Eric Coldwell | Baird |
Kevin Fischbeck | BofA Global Research |
Joanna Sylvia Gajuk | BofA Global Research |